Zero Candida Technologies (TSXV:ZCT) Shares Outstanding (EOP): 19.53 Mil (As of Dec. 2025)


TSXV:ZCT Zero Candida Technologies Inc TSXV:ZCT
14 GF Score
Price C$0.16
! 1 Warning Sign
View Full Analysis

What is Zero Candida Technologies Shares Outstanding (EOP)?

Zero Candida Technologies TSXV:ZCT 14 Shares Outstanding (EOP) is 19.53 Mil as of Dec. 2025. GuruFocus rates TSXV:ZCT with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Zero Candida Technologies's shares outstanding for the quarter that ended in Dec. 2025 was 19.53 Mil.

Zero Candida Technologies's quarterly shares outstanding stayed the same from Sep. 2025 (19.53 Mil) to Dec. 2025 (19.53 Mil).

Zero Candida Technologies's annual shares outstanding stayed the same from Jul. 2024 (19.53 Mil) to Dec. 2025 (19.53 Mil).


Zero Candida Technologies  (TSXV:ZCT) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Zero Candida Technologies Shares Outstanding (EOP) Related Terms


Zero Candida Technologies Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Zero Candida Technologies's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zero Candida Technologies Shares Outstanding (EOP) Chart

Zero Candida Technologies Annual Data
Trend Jul23 Jul24 Dec25
Shares Outstanding (EOP)
19.53 19.53 19.53

Zero Candida Technologies Quarterly Data
Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Mar25 Jun25 Sep25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.53 19.63 19.53 19.53 19.53

TSXV:ZCT vs ABT, SYK, MDT: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, Zero Candida Technologies's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zero Candida Technologies Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zero Candida Technologies's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Zero Candida Technologies's Shares Outstanding (EOP) falls into.


TSXV:ZCT
14GF Score
Zero Candida Technologies Inc TSXV:ZCT
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zero Candida Technologies Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 19.53 Mil mean?
Zero Candida Technologies (TSXV:ZCT) has a Shares Outstanding (EOP) of 19.53 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Zero Candida Technologies and its competitors.
Is Zero Candida Technologies' Shares Outstanding (EOP) too high?
Zero Candida Technologies' current Shares Outstanding (EOP) is 19.53 Mil. Overall, Zero Candida Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zero Candida Technologies' Shares Outstanding (EOP) compare to ABT and SYK?
Zero Candida Technologies' Shares Outstanding (EOP) of 19.53 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Zero Candida Technologies and its competitors. Zero Candida Technologies's current Shares Outstanding (EOP) is 19.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zero Candida Technologies stock overvalued right now?
Zero Candida Technologies (TSXV:ZCT) has a current Shares Outstanding (EOP) of 19.53 Mil. The current Shares Outstanding (EOP) is 19.53 Mil. Zero Candida Technologies' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Zero Candida Technologies (TSXV:ZCT), the current Shares Outstanding (EOP) is 19.53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zero Candida Technologies Business Description

Address 666 Burrard Street, Suite 500, Vancouver, BC, CAN, V6C 3P6
Zero Candida Technologies Inc is engaged in providing female healthcare solutions. The company technology uses a controlled Blue Light to destroy the fungus at record speed and without side effects. It focused on developing and commercializing several patents and patent applications concerning an AI smart tampon-like device, designed to treat Candidiasis and transfer medical information via Wi-Fi to the doctor.
14GF Score

Get the complete analysis for TSXV:ZCT

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.16
Price